Abstract

The International Commission on Radiological Protection (ICRP) is preparing a series of reports that will provide updated biokinetic and dosimetric models and dose coefficients for occupational intake of radionuclides. The biokinetic modelling scheme continues a trend in ICRP reports towards physiologically realistic descriptions of the time-dependent behaviour of absorbed radionuclides and their radioactive progeny. This paper proposes systemic biokinetic models for caesium isotopes and their ingrowing chain members and examines the dosimetric implications of the proposed models. Comparisons of D68 = tissue dose per unit input to blood based on current ICRP models for workers (ICRP Publication 68, 1994) with DP = corresponding values based on the proposed biokinetic models (but using the dosimetry models of Publication 68) yields the following ranges of the ratios DP:D68 for the tissues addressed in Publication 68: 0.5–25 for 130Cs (T1/2 = 29.2 min), 0.6–9.5 for 134mCs (2.9 h), 0.7–1.7 for 131Cs (9.69 d), 0.7–1.1 for 134Cs (2.06 y), 0.5–1.9 for 137Cs (30.2 y) and 0.2–3.7 for 135Cs (2.3 × 106 y). The large differences in the derived dose coefficients for some tissues and caesium isotopes, particularly short-lived isotopes, result mainly from differences in predictions of the time-dependent distributions of caesium in the body. For example, the proposed model and the current ICRP model for occupational intake of caesium predict peak kidney contents of ∼22% and ∼0.4%, respectively, following intravenous injection of stable caesium. Based on the proposed models for caesium and its progeny, the only dosimetrically significant chain members of caesium isotopes with half-life ≥10 min are 137mBa, which represents 32–85% of the estimated tissue doses from injected 137Cs, and 134Cs, which represents 4–53% of the estimated tissue doses from injected 134mCs.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call